AnaptysBio Correlations
| ANAB Stock | USD 49.73 1.83 3.82% |
The current 90-days correlation between AnaptysBio and Xencor Inc is 0.09 (i.e., Significant diversification). The correlation of AnaptysBio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
AnaptysBio Correlation With Market
Poor diversification
The correlation between AnaptysBio and DJI is 0.71 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding AnaptysBio and DJI in the same portfolio, assuming nothing else is changed.
AnaptysBio | Build AI portfolio with AnaptysBio Stock |
Moving together with AnaptysBio Stock
| 0.86 | DSGN | Design Therapeutics | PairCorr |
| 0.64 | ENGN | enGene Holdings Common | PairCorr |
| 0.81 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.63 | KYTX | Kyverna Therapeutics | PairCorr |
| 0.72 | MRKR | Marker Therapeutics | PairCorr |
| 0.87 | AVE | Avecho Biotechnology | PairCorr |
| 0.86 | ANNX | Annexon | PairCorr |
| 0.79 | SLDB | Solid Biosciences LLC | PairCorr |
| 0.8 | SVRA | Savara Inc | PairCorr |
| 0.64 | BOLT | Bolt Biotherapeutics | PairCorr |
| 0.7 | CADL | Candel Therapeutics | PairCorr |
Moving against AnaptysBio Stock
| 0.86 | EVGN | Evogene | PairCorr |
| 0.8 | IMRN | Immuron Ltd ADR | PairCorr |
| 0.76 | GNLX | Genelux Common | PairCorr |
| 0.74 | EDIT | Editas Medicine | PairCorr |
| 0.68 | QSI | QuantumSi | PairCorr |
| 0.63 | LYRA | Lyra Therapeutics | PairCorr |
| 0.61 | ABP | Abpro Holdings | PairCorr |
| 0.55 | DWTX | Dogwood Therapeutics | PairCorr |
| 0.49 | KRRO | Frequency Therapeutics | PairCorr |
| 0.42 | KURA | Kura Oncology | PairCorr |
| 0.33 | JUMP | Leveljump Healthcare Corp | PairCorr |
| 0.82 | ACXP | Acurx Pharmaceuticals LLC | PairCorr |
| 0.69 | MBIO | Mustang Bio | PairCorr |
| 0.56 | PROK | ProKidney Corp | PairCorr |
| 0.55 | PRQR | ProQR Therapeutics | PairCorr |
| 0.4 | MREO | Mereo BioPharma Group | PairCorr |
| 0.31 | RNAZ | Transcode Therapeutics | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between AnaptysBio Stock performing well and AnaptysBio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze AnaptysBio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| XNCR | 2.71 | (0.35) | 0.00 | (0.33) | 0.00 | 6.33 | 16.84 | |||
| OCS | 1.90 | 0.56 | 0.22 | 5.91 | 1.73 | 5.79 | 16.37 | |||
| PHAT | 2.84 | (0.08) | 0.00 | (0.24) | 0.00 | 5.99 | 24.16 | |||
| MNMD | 3.07 | 0.49 | 0.10 | (0.20) | 3.40 | 6.21 | 28.06 | |||
| URGN | 3.29 | 0.19 | 0.03 | (0.22) | 4.10 | 6.25 | 36.24 | |||
| NRIX | 3.11 | 0.38 | 0.10 | 0.79 | 3.19 | 7.07 | 27.63 | |||
| BBOT | 3.43 | (0.16) | 0.00 | (0.33) | 0.00 | 8.45 | 27.79 | |||
| KOD | 3.96 | 0.28 | 0.07 | 0.21 | 4.04 | 8.06 | 23.68 | |||
| DNTH | 2.85 | 0.53 | 0.15 | (0.92) | 2.73 | 8.00 | 23.32 | |||
| TSHA | 3.73 | (0.03) | 0.00 | (0.04) | 0.00 | 7.92 | 21.14 |
AnaptysBio Corporate Management
| Martin Dahl | Senior Research | Profile | |
| Monique Silva | Senior Affairs | Profile | |
| James MD | Advisor | Profile | |
| David McKeon | Senior Controller | Profile | |
| Beth Mueller | Senior Resources | Profile | |
| Priya Raina | Senior Operations | Profile | |
| FAAD MBA | Chief Officer | Profile |